Bonesupport
331
SEK
+4,81 %
Mindre end 1K følgere
BONEX
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Ownership
+4,81%
-6,76%
-14,43%
-4,34%
+9,82%
+51,14%
+715,27%
+1.103,64%
+934,38%
Bonesupport operates in the medical technology industry and focuses on the development and manufacture of bioceramic implants for bone repair and reconstruction. The company's products are aimed at surgeons and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. Bonesupport was founded in 1999 and is headquartered in Lund, Sweden.
Læs mereMarkedsværdi
22,1 mia. SEK
Aktieomsætning
28,4 mio. SEK
Omsætning
898,73 mio.
EBIT %
18,49 %
P/E
162,25
Udbytteafkast, %
-
Finanskalender
24.4
2025
Delårsrapport Q1'25
27.5
2025
Generalforsamling '25
15.7
2025
Delårsrapport Q2'25
Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper

Bonesupport, Audiocast with teleconference, Year end report, 2024
BONESUPPORT HOLDING AB (publ) – publishes year end report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Modular Finance IR Consensus: BONESUPPORT – Consensus estimates Q4 2024
BONESUPPORT HOLDING AB (publ) – Invitation to Conference Call and Webcast for Year-End Report 2024
CERAMENT® G AND CERAMENT® V contributes to improved survival rates
Change in BONESUPPORT’s Nomination Committee ahead of the 2025 Annual General Meeting following a change in ownership
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
Announced Insider Trading
Announced Insider Trading
Redeye: BONESUPPORT Q3 - Surprising on US sales and EBIT
